National Comprehensive Cancer Network

About The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
Development and Update of the NCCN Guidelines
Recent Updates to NCCN Guidelines®
NCCN Guidelines Panels-Meeting Schedule
NCCN Categories of Evidence and Consensus
NCCN Categories of Preference
NCCN Guidelines® Steering Committee
Transparency: Process and Recommendations
Submission Request to the NCCN Guidelines Panels
Submission Request History
NCCN Compendium®
About the NCCN Compendium®
Subscribe to the NCCN Compendium
No Longer Recommended Uses
NCCN Framework for Resource Stratification of NCCN Guidelines
(NCCN Framework™)

NCCN Guidelines® & Clinical Resources

NCCN Chemotherapy Order Template
Reviewer Acknowledgement

The NCCN Chemotherapy Order Template reviewers play a critical role in the development and maintenance of the NCCN Chemotherapy Order Templates®. Template reviewers consist of physicians, pharmacists and nurses from NCCN Member Institutions. They were selected based on their clinical expertise with systemic therapies as well as disease-specific subspecialty areas. NCCN Template content is reviewed annually based on the NCCN Clinical Practice Guidelines®, the NCCN Drugs & Biologics Compendium®, published drug information and research, and their clinical experience. NCCN would like to recognize and thank the following volunteer reviewers for contributing their time and expertise:

Acute Lymphoblastic Leukemia (ALL)

Barry Diamond, PharmD
University of Alabama at Birmingham Comprehensive Cancer Center

Rebecca J. Nelson, PharmD, BCOP
Moffitt Cancer Center

Claire Rummage, PharmD
University of Alabama at Birmingham Comprehensive Cancer Center

Ayman Saad, MD
University of Alabama at Birmingham Comprehensive Cancer Center

Bijal Shah, MD
Moffitt Cancer Center

Bladder Cancer

Thomas W. Flaig, MD
University of Colorado Cancer Center

Cervical/Uterine/Vulvar Cancers

Nadeem R. Abu-Rustum, MD
Memorial Sloan Kettering Cancer Center

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center

Kidney Cancer

M. Dror Michaelson, MD, PhD
Massachusetts General Hospital Cancer Center

Robert J. Motzer, MD
Memorial Sloan Kettering Cancer Center

Melanoma

Christopher K. Bichakjian, MD
University of Michigan Comprehensive Cancer Center

Anthony J. Olszanski, RPh, MD
Fox Chase Cancer Center

John A. Thompson, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Multiple Myeloma

Shaji K. Kumar, MD
Mayo Clinic Cancer Center

Myelodysplastic Syndromes (MDS)

Peter L. Greenberg, MD
Stanford Cancer Institute

NHL: Burkitt Lymphoma

Thomas M. Habermann, MD
Mayo Clinic Cancer Center

Kristen B. McCullough, PharmD, RPh
Mayo Clinic Cancer Center

NHL: AIDS-Related B-Cell Lymphomas

Ariela Noy, MD
Memorial Sloan Kettering Cancer Center

Erin Reid, MD
UC San Diego Moores Cancer Center

Non-Small Cell Lung Cancer

Wallace Akerley, MD
Huntsman Cancer Institute at the University of Utah

Courtney C. Cavalieri, PharmD, BCOP
Huntsman Cancer Institute at the University of Utah

Occult Primary

Keith D. Eaton, MD, PhD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Small Cell Lung Cancer

Gregory P. Kalemkerian, MD
University of Michigan Comprehensive Cancer Center

Multiple Disease States

Emily Mackler, PharmD, BCOP
Michigan Oncology Quality Consortium at the University of Michigan Comprehensive Cancer Center

Amy Seung, PharmD, BCOP
AssistRx